Physicochemical studies on Ciclopirox olamine complexes with divalent metal ions

International Journal of Pharmaceutics

Volumn 289, Issue 1-2, 2005, Pages 179-187

  Tarawneh, Ruba T ^a   Hamdan, Imad I ^a   Bani Jaber, Ahmad ^a   Darwish, Rula M ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Ciclopirox olamine; Metal ion complexes; Partition coefficient

Indexed keywords

ANTIFUNGAL AGENT; CALCIUM ION; CICLOPIROXOLAMINE; COPPER DERIVATIVE; FERROUS ION; MAGNESIUM ION; MANGANESE; METAL ION; ZINC ION;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG SYNTHESIS; FINITE ELEMENT ANALYSIS; INFRARED SPECTROSCOPY; MELTING POINT; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TITRIMETRY;

CALORIMETRY, DIFFERENTIAL SCANNING; CATIONS, DIVALENT; CHEMISTRY, PHARMACEUTICAL; ORGANOMETALLIC COMPOUNDS; PYRIDONES; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TRANSITION TEMPERATURE;

EID: 11844258773     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.11.009     Document Type: Article

References (26)

1. H.G. Alpermann, and E. Schutz Studies on the pharmacology and toxicology of CPO olamine Arzneimittelforschung 31 1981 1328 1332
2. M. Bohn, and K.T. Kraemer Dermato-pharmacology of Ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis J. Am. Acad. Dermatol. 43 2000 57 69
3. M. Bohn, and K.T. Kraemer The dermato-pharmacologic profile of CPO 8% nail lacquer J. Am. Podiatr. Med. Assoc. 90 2000 491 494
4. S. Brewer Solving Problems in Analytical Chemistry first ed. 1980 John Wiley and Sons New York
5. J.L. Buss, F.M. Torti, and S.V. Torti The role of iron chelation in cancer therapy Curr. Med. Chem. 10 2003 1021 1334
6. C.G. Ceschin-Roques, H. Hünel, S.M. Pruja-Bougaret, I. Lagarde, J. Vandemander, and L.G. Miche Ciclopirox olamine nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin Skin Pharmacol. 4 1991 89 94
7. P.M. Clement, H.M. Hanauske-Abel, E.C. Wolff, H.K. Kleinman, and M.H. Park The antifungal drug Ciclopirox inhibits deoxyhypusine and pruline hydroxylation, endothelial cell growth and angiogenesis in vitro Int. J. Cancer 100 2002 491 498
8. A.E. Finefork, A.I. Bush, and P.M. Doraiswamy Current status of metals as therapeutic targets in Alzheimer's disease J. Am. Geriatr. Soc. 51 2003 1143 1148
9. T. Fredriksson, and C. Savopoulos Comparative double blind study on Ciclopirox olamine cream and placebo cream in dermatophytoses Arzneimittelforschung 31 1981 1376 1378
10. A.K. Gupta, P. Fleckman, and R. Baran Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis J. Am. Acad. Dermatol. 43 2000 S70 S80
11. A.K. Gupta, I.E. Ryder, and R. Baran The use of topical therapies to treat onychomycosis Dermatol. Clin. 21 2003 481 489
12. + and phosphate in Candida albicans cells Arzneimittelforschung 31 1981 1323 1327
13. S.G. Jue, G.W. Daeson, and R.N. Brgden Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use Drugs 29 1985 330 341
14. H.M. Kellner, C. Arnold, O.E. Christ, H.G. Eckert, J. Herok, I. Hornke, and W. Rupp Pharmacokinetics and biotransformation of the antimycotic drug Ciclopirox olamine in animals and man after topical and systemic administration Arzneimittelforschung 31 1981 1337 1353
15. S.H. Leem, I.E. Park, I.S. Kim, J.Y. Chae, A. Sugino, and Y. Sunwoo The possible mechanism of action of Ciclopirox olamine in the yeast Saccharomyces cerevisiae Mol. Cells 15 2003 55 61
16. C.W. Levenson Iron and Parkinson's disease: chelators to the rescue? Nutr. Rev. 61 2003 311 313
17. B.M. Lomaestro, and G.R. Bailie Quinolone-cation interactions: a review DICP 25 1991 1249 1258
18. T. Matsukara, and H. Tanaka Applicability of zinc complex of l-canosine for medial use Biochemistry 6597 2000 817 823
19. M. Niewerth, M. Schaller, H.C. Korting, and B. Hube Mode of action of Ciclopirox olamine on Candida albicans Mycoses 45 2002 63 68
20. M. Niewerth, D. Kunze, M. Seibold, H.C. Korting, and B. Hube Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors Antimicrob. Agents Chemother. 47 2003 1805 1817
21. J.L. Pierre, P. Baret, and G. Serratrice Hydroxyquinolines as iron chelators Curr. Med. Chem. 10 2003 1077 1084
22. B. Pradines, J. Millet, and M. Henry Iron chelation in anti-malarial therapy Med. Trop. 63 2003 119 130
23. D.R. Richardson Iron chelators as therapeutic agents for the treatment of cancer Crit. Rev. Oncol. Hematol. 42 2002 267 281
24. V.N. Sehgal Ciclopirox: a new topical pyrodonium antimycotic agent. A double blind study in superficial dermatomycoses Br. J. Dermatol. 95 1976 83 88
25. J. Sharma, A.K. Singla, and S. Dhawan Zinc-naproxen complex: synthesis physicochemical and biological evaluation Int. J. Pharm. 260 2003 217 227
26. X. Wang A chelate theory for the mechanism of action of aspirin like drugs Med. Hypotheses 50 1998 239 251